Home About Us Prestigious Accreditations Our Physicians Our Services Frequently Asked Questions Links Directions to our office Contact Us

FREQUENTLY ASKED QUESTONS

Abdominal Aortic Aneurysm

Ablation

Angina Pectoris

Angiogram

Aortic Stenosis

Arrhythmia

Aspirin and Cardiovascular Disease

Atrial Fibrillation

Automatic Implantable Cardioverter-Defibrillator

Balloon Angioplasty

Bradycardia

Cardiac Catheterization

Cardiomyopathy

Cardiopulmonary Resuscitation CPR Statistics

Cardioversion and Defibrillation

Carotid Endarterectomy

Cholesterol

Congenital Heart Disease

Congestive Heart Failure

Coronary Artery Disease

Coumadin

Defibrillator Implant

Deep Venous Thrombosis

Electrophysiology Study

Endocarditis

Event Recorder

Food Labels

Heart Attack

Heart Failure Device Implant

Heart Transplantation

Holter Monitoring

Hypertension

Low Ejection Fraction

Low Fat Diet Guidelines

Marfan Syndrome

Mitral Regurgitation

Mitral Valve Prolapse

Myocardial Infarction

Myocarditis

Obesity

Pacemaker Implant

Pacemakers

Pericarditis

Peripheral Vascular Disease

Sex in Heart Disease or Stroke

Stent Implant

Stroke

Stroke Recovery and Rehabilitation

Sudden Cardiac Arrest

Supraventricular Tachycardia

Syncope

Tilt Table

Transmyocardial Revascularization

Ventricular Fibrillation

Ventricular Tachycardia

Viagra

Vitamins and the Heart

Weight Control and Smoking

Back to FAQs index page


Frequently Asked Questions
<Back to FAQs index page>

Presented in part with the support of Novartis Pharmaceuticals and Boston Scientific / Guidant

Heart Attack

1. For Information
2. Facts About Heart and Heart-Lung Transplants


For Information

See Myocardial Infarction


Facts About Heart and Heart-Lung Transplants

In the three decades since the performance of the first human heart transplant in December 1967, the procedure has changed from an experimental operation to an established treatment for advanced heart disease. Approximately 2,300 heart transplants are performed each year in the United States.

In 1981, combined heart and lung transplants began to be used to treat patients with conditions that severely damage both these organs. As of 1995, about 500 people in the United States and 2,000 worldwide have received heart-lung transplants.

There have been two main barriers to increasing the number of successful operations. In 1983, the first barrier to successful transplantations--rejection of the donor organ by the patient--was overcome. The drug cyclosporine was introduced to suppress rejection of a donor heart or heart-lung by the patient's body. Cyclosporine and other medications to control rejection have significantly improved the survival of transplant patients. About 80 percent of heart transplant patients survive 1 year or more. About 60 percent of heart-lung transplants live at least 1 year after surgery. Research is under way to develop even better ways to control transplant rejection and improve survival.

Organ availability is the second barrier to increasing the number of successful transplantations. Hospitals and organizations nationwide are trying to increase public awareness of this problem and improve organ distribution.

 


| Home | About Us | Prestigious Accreditations | Physicians | Services | FAQs | Links | Directions | Disclaimer | Contact Us |

Cardiology Associates of Fort Lauderdale, P.A.
4725 N. Federal Hwy, Suite #401
The Jim Moran Heart and Vascular Center
Fort Lauderdale, FL 33308
Phone: (954) 772-2136
Fax: (954) 772-7156

©2010, Cardiology Associates of Fort Lauderdale, P.A. All rights reserved.
Web site by Ticsay Internet.